# FDA Inspection 1102925 - HCG Manavata Cancer Centre - September 27, 2019

Source: https://www.globalkeysolutions.net/records/fda_inspections/hcg-manavata-cancer-centre/a76202ca-498f-4f7f-8af7-b93d755227ca
Source feed: FDA_Inspections

> FDA Inspection 1102925 for HCG Manavata Cancer Centre on September 27, 2019. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1102925
- Company Name: HCG Manavata Cancer Centre
- Inspection Date: 2019-09-27
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1221683 - 2023-09-27](https://www.globalkeysolutions.net/records/fda_inspections/hcg-manavata-cancer-centre/f8215b21-25f6-415d-bc0d-07953504d70f)
- [FDA Inspection 1179266 - 2022-08-06](https://www.globalkeysolutions.net/records/fda_inspections/hcg-manavata-cancer-centre/6508cb4d-4531-4482-b6b9-0c94646baaba)

Company: https://www.globalkeysolutions.net/companies/hcg-manavata-cancer-centre/b5266eff-a6f7-4c2f-b649-63920b7d709e

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c